Last updated: July 29, 2024
Sponsor: China-Japan Friendship Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dermatomyositis (Connective Tissue Disease)
Sjogren's Syndrome
Treatment
N/AClinical Study ID
NCT06528197
2024-1-4065
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Meets the 2002 AECG or 2016 ACR/EULAR classification criteria of primary Sjögren'ssyndrome.
Exclusion
Exclusion Criteria:
Comorbid connective tissue disease other than the disease under research.
Women who are pregnant or breastfeeding.
Combined severe cardiovascular or cerebrovascular disease, hepatic or renal failure,or severe malignant tumors.
Other conditions (e.g., cognitive impairment) that the investigators considerineligible for enrollment.
Study Design
Total Participants: 1000
Study Start date:
July 04, 2024
Estimated Completion Date:
December 31, 2026
Connect with a study center
Jiaqi Chen
Beijing, Beijing 100029
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.